Literature DB >> 2831651

Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs.

S Makino1, C K Shieh, J G Keck, M M Lai.   

Abstract

The mechanism of synthesis of the defective viral RNAs in cells infected with defective-interfering (DI) particles of mouse hepatitis virus was studied. Two DI-specific RNA species, DIssA of genomic size and DIssE of subgenomic size, were detected in DI-infected cells. Purified DI particles, however, were found to contain predominantly DIssA and only a trace amount of DIssE RNA. Despite its negligible amount, the DIssE RNA in virions appears to serve as the template for the synthesis of DIssE RNA in infected cells. This conclusion was supported by two studies. First, the uv target size for DIssE RNA synthesis is significantly smaller than that for DIssA. Second, when purified DIssE RNA was transfected into cells which had been infected with a helper virus, DIssE RNA could replicate itself and became a predominant RNA species in the infected cells. Thus, DIssE RNA was not synthesized from the genomic RNA of DI particles. By studying the relationship between virus dilution and the amount of intracellular viral RNA synthesis, we have further shown that DIssE RNA synthesis requires a helper function, but it does not utilize the leader sequence of the helper virus. In contrast, DIssA synthesis appears to be helper-independent and can replicate itself. Thus DIssA codes for a functional RNA polymerase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831651      PMCID: PMC7131348          DOI: 10.1016/0042-6822(88)90237-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Genomic RNA of the murine coronavirus JHM.

Authors:  H Wege; A Müller; V ter Meulen
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

2.  Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus.

Authors:  S Makino; N Fujioka; K Fujiwara
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Characterization of two RNA polymerase activities induced by mouse hepatitis virus.

Authors:  P R Brayton; M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

4.  In vitro replication of mouse hepatitis virus strain A59.

Authors:  S R Compton; D B Rogers; K V Holmes; D Fertsch; J Remenick; J J McGowan
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus.

Authors:  M M Lai; R S Baric; P R Brayton; S A Stohlman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain.

Authors:  S Makino; F Taguchi; N Hirano; K Fujiwara
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

7.  Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases.

Authors:  P R Brayton; S A Stohlman; M M Lai
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

8.  The virus-specific intracellular RNA species of two murine coronaviruses: MHV-a59 and MHV-JHM.

Authors:  J L Leibowitz; K C Wilhelmsen; C W Bond
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

9.  Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription.

Authors:  R S Baric; S A Stohlman; M K Razavi; M M Lai
Journal:  Virus Res       Date:  1985-07       Impact factor: 3.303

10.  Characterization of small plaque mutants of mouse hepatitis virus, JHM strain.

Authors:  S Makino; F Taguchi; M Hayami; K Fujiwara
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

View more
  42 in total

1.  Characterization of an essential RNA secondary structure in the 3' untranslated region of the murine coronavirus genome.

Authors:  B Hsue; T Hartshorne; P S Masters
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations.

Authors:  R J de Groot; R G van der Most; W J Spaan
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs.

Authors:  R G van der Most; P J Bredenbeek; W J Spaan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 5.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

6.  A bulged stem-loop structure in the 3' untranslated region of the genome of the coronavirus mouse hepatitis virus is essential for replication.

Authors:  B Hsue; P S Masters
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  A subgenomic mRNA transcript of the coronavirus mouse hepatitis virus strain A59 defective interfering (DI) RNA is packaged when it contains the DI packaging signal.

Authors:  E C Bos; J C Dobbe; W Luytjes; W J Spaan
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  High-frequency leader sequence switching during coronavirus defective interfering RNA replication.

Authors:  S Makino; M M Lai
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Mutagenic analysis of the coronavirus intergenic consensus sequence.

Authors:  M Joo; S Makino
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication.

Authors:  Y J Lin; M M Lai
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.